Antibody development against hard-to-produce antigens
A Belgian SME has developed a novel immunization method that generates efficient antibodies without using recombinant proteins or purified proteins.
Poly- and monoclonal antibodies are delivered even against self-antigens, membrane or insoluble proteins, low immunogenic proteins or peptides. The company seeks industrial and academic partners active in biotechnology R&D for technical collaboration (for development of therapeutic or diagnostic preclinical candidates for example).
Closing date: 14/02/2015